Kerr W. Holbrook - 06 Mar 2023 Form 4 Insider Report for AVANOS MEDICAL, INC. (AVNS)

Role
SVP, GM Chronic Care
Signature
/s/ Mojirade James, as attorney-in-fact for Kerr W. Holbrook
Issuer symbol
AVNS
Transactions as of
06 Mar 2023
Net transactions value
-$44,815
Form type
4
Filing time
07 Mar 2023, 15:43:18 UTC
Previous filing
08 Nov 2022
Next filing
09 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVNS Common Stock Award $0 +24,233 +74% $0.000000 57,097 06 Mar 2023 Direct F1, F2
transaction AVNS Common Stock Tax liability $44,815 -1,513 -2.6% $29.62 55,584 06 Mar 2023 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents time-based restricted share units awarded pursuant to the Issuer's 2021 Long Term Incentive Plan. The award will vest 1/3 on March 6, 2024, 1/3 on March 6, 2025 and 1/3 on March 6, 2026.
F2 Total beneficially owned includes 249 shares acquired on December 30, 2022 and 510 shares acquired on June 30, 2022 under the Issuer's Employee Stock Purchase Plan.
F3 Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of time-based restricted share units awarded to the Reporting Person on March 4, 2022, 1/3 of which vested on March 4, 2023, with the remainder vesting 1/3 on March 4, 2024 and 1/3 on March 4, 2025.